Screener
Amgen AMGN Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Amgen in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The source filing: Amgen’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000318154-26-000126
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $2,865 | $2,367 |
| Accrued liabilities | 17,192 | 18,523 |
| Current portion of long-term debt | 5,445 | 4,599 |
| Total current liabilities | 25,502 | 25,489 |
| Long-term debt | 51,859 | 50,005 |
| Long-term deferred tax liabilities | 1,301 | 1,366 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is Amgen's accrued expenses?
- Amgen (AMGN) reported accrued expenses of $17.19B in Q2 2026.
- How has Amgen's accrued expenses changed year-over-year?
- Amgen's accrued expenses increased by 14.4% year-over-year, from $15.02B to $17.19B.
- What is the long-term trend for Amgen's accrued expenses?
- Over 5 years (2020 to 2025), Amgen's accrued expenses has grown at a 12.8% compound annual growth rate (CAGR), from $10.14B to $18.52B.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Amgen's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude